Jason Shandell

Jason B. Shandell is currently Director at Lannett Co., Inc. since 2023.
He is also Director at Amphastar Nanjing Pharmaceuticals Co., Ltd., International Medication Systems (UK) Ltd., and Amphastar UK Ltd. since 2016.
Formerly, Mr. Shandell was Technology Director at Move, Inc. from 2006 to 2008.
He was President, Director & General Counsel at Amphastar Pharmaceuticals, Inc. from 2013 to 2020.
He worked as Corporate Counsel at Amgen, Inc. in 2005 and as Associate at Shaw Pittman LLP in 2004.
He was President at International Medication Systems Ltd. Mr. Shandell completed graduate and MBA degrees at the University of Southern California in 2000 and an undergraduate degree at the University of California, Santa Barbara in 1996.